Georgia Bio Blog

The Only Way We’ll Know When We Need COVID-19 Boosters

June 24, 2021

Research can tell us only so much. The rest is a waiting game. Midway through America’s first mass-immunization campaign against the coronavirus, experts are already girding themselves for the next. The speedy rollout of wildly effective shots in countries such as the United States, where more than half the population has received at least one…

Read More

NIH antibody study uncovers millions of hidden, uncounted COVID-19 cases

June 24, 2021

During the first six months of the COVID-19 pandemic when diagnostic tests were scarce, the spread of the coronavirus reached far further than initially known—with the official count potentially missing the mark by millions to tens of millions of cases, according to a new antibody study conducted by the National Institutes of Health. Researchers estimate…

Read More

The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better

June 24, 2021

Persistent hype around mRNA vaccine technology is now distracting us from other ways to end the pandemic. At the end of January, reports that yet another COVID-19 vaccine had succeeded in its clinical trials—this one offering about 70 percent protection—were front-page news in the United States, and occasioned push alerts on millions of phones. But when the…

Read More

Delta variant of SARS-CoV-2 is now in 85 countries and accounts for 20% of U.S. infections in past two weeks

June 24, 2021

Highly infectious variant is creating new waves of cases in Europe, the U.S., Israel and Australia The delta variant of the coronavirus causing COVID-19 has now been detected in 85 countries, according to the World Health Organization, and remains a variant of concern with evidence suggesting it may reduce vaccine protection against infection and disease.…

Read More

Study confirms GSK-Vir antibody drug reduces hospitalization, death in COVID-19 patients

June 23, 2021

June 21 (Reuters) – GlaxoSmithKline Plc (GSK.L) and Vir Biotechnology (VIR.O) said on Monday final results from a late-stage study of their monoclonal antibody confirmed it significantly reduced hospitalization and death among high-risk COVID-19 patients when given early in the disease. The treatment, sotrovimab, received an emergency use authorization from the U.S. Food and Drug Administration in May, while…

Read More

A surprising pandemic side effect: People are more engaged with their health

June 23, 2021

About a month ago, one of our patients, a man in his mid-40s, came to the clinic for an in-person visit for the first time in more than 12 months. For the past few years, he’s struggled with sky-high blood pressure and always seemed to be teetering on the edge of a major stroke. But…

Read More

Vaccine effort turns into slog as infectious variant spreads

June 23, 2021

As cases tumble and states reopen, the potential final stage in the U.S. campaign to vanquish COVID-19 is turning into a slog, with a worrisome variant gaining a bigger foothold and lotteries and other prizes failing to persuade some Americans to get vaccinated. “The last half, the last mile, the last quarter-mile always requires more…

Read More

Scientists prepare for next coronavirus pandemic, maybe in 2028?

June 23, 2021

New drug target found for future and current coronaviruses ‘God forbid we need this, but we’ll be ready’ Medication would be taken early in the disease, so you don’t get as sick Future drug could also treat common cold Scientists are already preparing for a possible next coronavirus pandemic to strike, keeping with the seven-year…

Read More

NIH releases a plan to confront structural racism. Critics say it’s not enough

June 11, 2021

Saying structural racism is a chronic problem throughout biomedical research and within their own walls, leaders of the National Institutes of Health Thursday unveiled a plan intended to eliminate a big gap in grants awarded to white and minority scientists and boost funding for research on health disparities. The agency, the largest funder of biomedical research in…

Read More